pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

6,918 products tracked · 1,486 matching

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
  • Phase 2
    exendin-(9-39)
    Hyperinsulinemia Children's Hospital of Philadelphia
  • Phase 2
    exeporfinium chloride
    exeporfinium chloride [INN]
    Hospital Acquired Methicillin-Resistant Staphylococcus au… AMR Bio Ltd
  • Phase 2
    ezeprogind
    ezeprogind [INN]
    Progressive Supranuclear Palsy AlzProtect SAS
  • Phase 2
← prev
page 37 of 50
next →
131
Pain89
Neurology1
ezurpimtrostat
ezurpimtrostat [INN]
Bile Duct Cancer (Cholangiocarcinoma)
Genfit SA
  • Phase 2
    famzeretcel
    famzeretcel [INN]
    Retinitis Pigmentosa (Retinitis) jCyte Inc
  • Phase 2
    farletuzumab ecteribulin
    farletuzumab ecteribulin
    Triple-Negative Breast Cancer (TNBC) Eisai Co Ltd
  • Phase 2
    fasudil
    BRAVYL (fasudil [INN])
    Amyotrophic Lateral Sclerosis Woolsey Pharmaceuticals Inc
  • Phase 2
    fenretinide
    fenretinide
    Dengue Fever$ILPLF Island Pharmaceuticals Ltd
  • Phase 2
    fexapotide triflutate
    fexapotide triflutate
    Prostate Cancer$NYMXF NYMOX PHARMACEUTICAL CORP
  • Phase 2
    flixebrutinib
    flixebrutinib
    Chronic Idiopathic Myelofibrosis (Primary Myelofibrosis) Telios Pharma Inc
  • Phase 2
    flucytosine ER + vocimagene amiretrorepvec
    flucytosine + vocimagene amiretrorepvec
    Glioblastoma Multiforme (GBM) Denovo Biopharma LLC
  • Phase 2
    foralumab
    foralumab [INN]
    Alzheimer's Disease$TLSA Tiziana Life Sciences Ltd
  • Phase 2
    foscenvivint
    foscenvivint [INN]
    Colorectal Cancer Eisai Co Ltd
  • Phase 2
    fosdesdenosine sipalabenamide
    fosdesdenosine sipalabenamide [INN]
    Metastatic Melanoma$NCNA NuCana plc
  • Phase 2
    foselutoclax
    foselutoclax [INN]
    Diabetic Macular Edema Unity Biotechnology Inc
  • Phase 2
    fosigotifator sodium tromethamine
    fosigotifator sodium tromethamine
    Unspecified Central Nervous System Disorders Calico Life Sciences LLC
  • Phase 2
    fostroxacitabine bralpamide hydrochloride
    fostroxacitabine bralpamide hydrochloride
    Hepatocellular Carcinoma Medivir AB
  • Phase 2
    froniglutide
    froniglutide [INN]
    Duchenne Muscular Dystrophy ImmunoForge Co Ltd
  • Phase 2
    fulzerasib
    fulzerasib [INN]
    Metastatic Colorectal Cancer GenFleet Therapeutics (Shanghai) Inc
  • Phase 2
    furaprevir
    furaprevir [INN]
    Hepatitis C TaiGen Biotechnology Co Ltd
  • Phase 2
    fusidic acid
    fusidic acid
    Burkholderia pseudomallei Infections (Melioidosis) Aceragen Inc
  • Phase 2
    galicaftor
    galicaftor
    Cystic Fibrosis$SION Sionna Therapeutics, Inc.
  • Phase 2
    garetatug rezetecan
    garetatug rezetecan [INN]
    Gastric Cancer Jiangsu Hengrui Pharmaceuticals Co Ltd
  • Phase 2
    gedeptin
    Nasopharyngeal Cancer$GOVX GeoVax Labs, Inc.
  • Phase 2
    gemlapodect
    gemlapodect
    Stammering (Stuttering) Noema Pharma AG
  • Phase 2
    gemogenovatucel-T
    Vigil (gemogenovatucel-T)
    Endometrial Cancer Gradalis Inc
  • Phase 2
    genistein
    genistein
    Pulmonary Fibrosis Humanetics Corp
  • Phase 2
    gilavebexagene anvuparvovec
    gilavebexagene anvuparvovec
    Tay-Sachs Disease University of Massachusetts
  • Phase 2
    glecirasib
    glecirasib [INN]
    Non-Small Cell Lung Cancer Jacobio Pharmaceuticals Group Co Ltd
  • Phase 2
    gocatamig
    gocatamig
    Small-Cell Lung Cancer$MRK Merck & Co., Inc.